slides · global inventory
Legend
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,863
Current window 9,631-9,660
Pages 463
Rows per page 30
Component
9,631-9,660 of 13,863
13
The slide functions as a summary of a published scientific paper/case study.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
36
The slide uses a growth curve to illustrate technological progression over time.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
13
Includes CAGR metrics for specific periods and highlights key acquisition and economic events.Advantage Solutions | Investor Presentation Deck | 27 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
29
The chart illustrates the shift from a single-product revenue base to a more diversified portfolio including VIVITROL, ARISTADA, VUMERITY, and LYBALVI.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations 1 hit
32
Uses a visual comparison of bar charts to illustrate duration matching and a checklist table for liability characteristics.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
04
Includes a legend for technical acronyms at the bottom.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
06
The slide uses a four-column layout to structure the disease overview.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Problem1 hit
07
Uses a geographic map and a nested circle diagram to illustrate the treatment gap.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
13
The slide displays 8 individual patient case studies (Pt 46, 51, 52, 53, 56, 58, 59, 60, 61).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
21
The chart uses a horizontal bar format to represent clinical trial stages (Preclinical to Commercial) for multiple indications under four main programs (VYVGART, Efgartigimod, ARGX-117, ARGX-119).argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations 1 hit
04
Includes headshots and role descriptions for key leadership figures.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Current StateLoop · Golden Circle1 hit
14
Includes a map of Africa highlighting current and planned program countries.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
17
The slide uses a process-flow style layout to connect study design to efficacy outcomes.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
33
The chart displays efficacy trends for different dosing regimens of BEN-2293 compared to placebo.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations 1 hit
11
The slide uses a donut chart to show the shift in audience engagement distribution over time.BuzzFeed | Investor Presentation Deck | 27 slides · BuzzFeed
Pitch deck Investor relations Beat · Business Model1 hit
20
The chart highlights a significant spike in COVID-19 admissions in Jan 2022 (21.1) compared to a much lower rate in Nov 2022 (0.3).Cano Health | Results Presentation Deck | 21 slides · Cano Health
Deck Investor relations Beat · Action1 hit
15
The table uses a color-coded heatmap (green/pink) to indicate positive vs negative characteristics of trial design and outcomes.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
20
The chart shows a dose-response curve where longer incubation times (48+ hours) shift the curve to the left compared to 24 hours, indicating higher potency/efficacy with sustained exposure.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
10
The slide highlights that expansion is possible without take-or-pay obligations.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
The chart uses bubble size and color to represent job volume and education level, respectively. An arrow indicates a shift toward 'Knowledge', 'Digital skills', and 'Credentials' as a response.Coursera | Investor Day Presentation Deck | 131 slides · Coursera
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
21
The chart uses bubble size to represent employment volume and color to represent education level. An arrow indicates the potential shift of knowledge workers toward higher automation risk due to Generative AI.Coursera | Investor Day Presentation Deck | 131 slides · Coursera
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
48
The slide uses a grid-like layout to display various industry-partnered certification programs.Coursera | Investor Day Presentation Deck | 131 slides · Coursera
Conference presentation Investor relations 1 hit
115
The 2023E bar is outlined to indicate it is a projection/guidance.Coursera | Investor Day Presentation Deck | 131 slides · Coursera
Conference presentation Investor relations 1 hit
18
The table uses a matrix format to map specific credit rating tiers (columns) to individual banks (rows) using agency-specific codes.Credit Suisse | Credit Presentation Deck | 20 slides · Credit Suisse
Conference presentation Investor relations 1 hit
19
The table uses a matrix-like layout to map specific bank instruments to their respective credit rating tiers.Credit Suisse | Credit Presentation Deck | 20 slides · Credit Suisse
Conference presentation Investor relations 1 hit
18
The chart shows a significant decline in multiples for BGRY and Emerging industrial technology since the de-SPAC event.Credit Suisse | Investment Banking Pitch Book | 21 slides · Credit Suisse
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
18
The chart tracks valuation multiples from July 2021 to March 2023.Credit Suisse | Investment Banking Pitch Book | 21 slides · Credit Suisse
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
30
The chart shows a series of $200M-$250M authorizations from 2017 to 2022.Yelp | Investor Presentation Deck | 42 slides · Yelp
Pitch deck Investor relations 1 hit
37
The 2023E bar includes a shaded area representing the range $1.29B - $1.31B.Yelp | Investor Presentation Deck | 42 slides · Yelp
Pitch deck Investor relations Beat · Financials1 hit
39
Yelp | Investor Presentation Deck | 42 slidesYelp | Investor Presentation Deck | 42 slides · Yelp
Pitch deck Investor relations Beat · Financials1 hit